Close

Spectranetics' (SPNC) Stellarex 0.014” DCB Receives CE Mark

November 21, 2016 4:06 PM EST Send to a Friend
The Spectranetics Corporation (Nasdaq: SPNC) announced that its Stellarex 0.014” Drug-coated Angioplasty Balloon (DCB) has received the CE mark. The ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login